Ralph Levitt
- Oncology top 1%
- Cancer Treatment and Pharmacology 12
- HER2/EGFR in Cancer Research 8
- Lung Cancer Research Studies 8
- Colorectal Cancer Treatments and Studies 7
- Hepatology top 2%
- Genetics top 2%
- Glioma Diagnosis and Treatment 8
- Chronic Lymphocytic Leukemia Research 5
- Internal Medicine top 5%
- Hematology top 5%
-
- Neuroendocrine Tumor Research Advances 7
-
- Brain Metastases and Treatment 6
- Co-authors
- James E. KrookLoren K. TschetterJ A MailliardJames B. GerstnerJeff A. SloanSteven R. AlbertsHarry S. WieandCarl G. Kardinal
- Cited by
- OncologyHepatologyGenetics
- Journals
- Journal of Clinical Oncology (15 papers)Cancer (10 papers)Journal of Neuro-Oncology (4 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Ralph Levitt
67 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 110
- Oncology 2.1k
- Hepatology 479
- Genetics 523
- Internal Medicine 128
- Hematology 348
Countries citing papers authored by Ralph Levitt
This map shows the geographic impact of Ralph Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Levitt more than expected).
Fields of papers citing papers by Ralph Levitt
This network shows the impact of papers produced by Ralph Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Levitt. The network helps show where Ralph Levitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ralph Levitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 9 | |
| 2 | 2006 | 86 | |
| 3 | 2006 | 132 | |
| 4 | 2004 | 30 | |
| 5 | 2003 | 12 | |
| 6 | 2003 | 49 | |
| 7 | 2002 | 12 | |
| 8 | Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma. | 2002 | 22 |
| 9 | 2002 | 41 | |
| 10 | 2002 | 29 | |
| 11 | 2002 | 8 | |
| 12 | 2001 | 10 | |
| 13 | 1999 | 18 | |
| 14 | 1999 | 11 | |
| 15 | 1997 | 22 | |
| 16 | 1997 | 220 | |
| 17 | 1995 | 25 | |
| 18 | 1994 | 95 | |
| 19 | 1991 | 91 | |
| 20 | 1990 | 24 |
About Ralph Levitt
Ralph Levitt is a scholar working on Genetics, Oncology and Internal Medicine, having authored 67 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Glioma Diagnosis and Treatment (8 papers), HER2/EGFR in Cancer Research (8 papers), Lung Cancer Research Studies (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Brain Metastases and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Oncology (2.1k citations), Hepatology (479 citations) and Genetics (523 citations). Ralph Levitt has collaborated with scholars based in United States, India and Canada. Frequent co-authors include James E. Krook, Loren K. Tschetter, J A Mailliard, James B. Gerstner, Jeff A. Sloan, Steven R. Alberts, Harry S. Wieand, Carl G. Kardinal, Richard M. Goldberg and Kendrith M. Rowland. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Journal of Neuro-Oncology, Lung Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.